Pharmacokinetic considerations in the treatment of hypertension in risperidone-medicated patients - thinking of clinically relevant CYP2D6 interactions

Michael Paulzen; Ekkehard Haen; Gerhard Gruender; Sarah E. Lammertz; Benedikt Stegmann; Koen R. J. Schruers; Sebastian Walther; Georgios Schoretsanitis

doi:10.1177/0269881116650390

Pharmacokinetic considerations in the treatment of hypertension in risperidone-medicated patients - thinking of clinically relevant CYP2D6 interactions

Michael Paulzen, Ekkehard Haen, Gerhard Gruender, Sarah E. Lammertz, Benedikt Stegmann, Koen R. J. Schruers, Sebastian Walther, Georgios Schoretsanitis

MHeNs - Mental Health

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	803-809
Journal	Journal of Psychopharmacology
Volume	30
Issue number	8
DOIs	https://doi.org/10.1177/0269881116650390
Publication status	Published - Aug 2016

Keywords

Therapeutic drug monitoring
risperidone
amlodipine
metoprolol
CYP2D6
interaction
pharmacokinetics

Access to Document

10.1177/0269881116650390

Cite this

Paulzen, M., Haen, E., Gruender, G., Lammertz, S. E., Stegmann, B., Schruers, K. R. J., Walther, S., & Schoretsanitis, G. (2016). Pharmacokinetic considerations in the treatment of hypertension in risperidone-medicated patients - thinking of clinically relevant CYP2D6 interactions. Journal of Psychopharmacology, 30(8), 803-809. https://doi.org/10.1177/0269881116650390

Paulzen, Michael ; Haen, Ekkehard ; Gruender, Gerhard ; Lammertz, Sarah E. ; Stegmann, Benedikt ; Schruers, Koen R. J. ; Walther, Sebastian ; Schoretsanitis, Georgios. / Pharmacokinetic considerations in the treatment of hypertension in risperidone-medicated patients - thinking of clinically relevant CYP2D6 interactions. In: Journal of Psychopharmacology. 2016 ; Vol. 30, No. 8. pp. 803-809.

@article{dc144aa41e454934803ec841e95df4ab,

title = "Pharmacokinetic considerations in the treatment of hypertension in risperidone-medicated patients - thinking of clinically relevant CYP2D6 interactions",

keywords = "Therapeutic drug monitoring, risperidone, amlodipine, metoprolol, CYP2D6, interaction, pharmacokinetics",

author = "Michael Paulzen and Ekkehard Haen and Gerhard Gruender and Lammertz, {Sarah E.} and Benedikt Stegmann and Schruers, {Koen R. J.} and Sebastian Walther and Georgios Schoretsanitis",

year = "2016",

month = aug,

doi = "10.1177/0269881116650390",

language = "English",

volume = "30",

pages = "803--809",

journal = "Journal of Psychopharmacology",

issn = "0269-8811",

publisher = "SAGE Publications Ltd",

number = "8",

}

Pharmacokinetic considerations in the treatment of hypertension in risperidone-medicated patients - thinking of clinically relevant CYP2D6 interactions. / Paulzen, Michael; Haen, Ekkehard; Gruender, Gerhard; Lammertz, Sarah E.; Stegmann, Benedikt; Schruers, Koen R. J.; Walther, Sebastian; Schoretsanitis, Georgios.

In: Journal of Psychopharmacology, Vol. 30, No. 8, 08.2016, p. 803-809.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Pharmacokinetic considerations in the treatment of hypertension in risperidone-medicated patients - thinking of clinically relevant CYP2D6 interactions

AU - Paulzen, Michael

AU - Haen, Ekkehard

AU - Gruender, Gerhard

AU - Lammertz, Sarah E.

AU - Stegmann, Benedikt

AU - Schruers, Koen R. J.

AU - Walther, Sebastian

AU - Schoretsanitis, Georgios

PY - 2016/8

Y1 - 2016/8

KW - Therapeutic drug monitoring

KW - risperidone

KW - amlodipine

KW - metoprolol

KW - CYP2D6

KW - interaction

KW - pharmacokinetics

U2 - 10.1177/0269881116650390

DO - 10.1177/0269881116650390

M3 - Article

VL - 30

SP - 803

EP - 809

JO - Journal of Psychopharmacology

JF - Journal of Psychopharmacology

SN - 0269-8811

IS - 8

ER -